Experimental and clinic-opathologic study on the relationship between transcription factor Egr-1 and esophageal carcinoma

World Journal of Gastroenterology

Volumn 7, Issue 4, 2001, Pages 490-495

  Wu, M Y ^a   Chen, M H ^a   Liang, Y R ^a   Meng, G Z ^a   Yang, H X ^a   Zhuang, C X ^a  

^a SHANTOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; LIPOFECTAMINE; MESSENGER RNA; PROTEIN; TRANSCRIPTION FACTOR EGR 1; DNA BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN; EGR1 PROTEIN, MOUSE; IMMEDIATE EARLY PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM DYSPLASIA; ESOPHAGUS CARCINOMA; EXPRESSION VECTOR; GENE THERAPY; GENETIC TRANSFECTION; GROWTH CURVE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PATHOLOGY; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SCID MOUSE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ANIMAL; CARCINOGEN TESTING; CELL CULTURE; CELL DIVISION; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; MOUSE MUTANT; PATHOPHYSIOLOGY;

ANIMALS; BLOTTING, WESTERN; CARCINOGENICITY TESTS; CELL DIVISION; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, SCID; PLASMIDS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034742273     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i4.490     Document Type: Article

References (52)

1. Comparative studies on epithelial lesions at gastric cardia and pyloric antrum in subjects from a high incidence area for esophageal cancer in Henan, China
2. Over-expression of P53 and its risk factors in esophageal cancer in urban areas of Xi'an
3. Advance in molecular studies on esophageal cancer
4. Diagnosis and treatment of esophageal cancer
5. p53 gene mutations in multifocal esophageal precancerous and cancerous lesions in patients with esophageal cancer in high-risk northern China
6. Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China
7. A preliminary study on ras protein expression in human esophageal cancer and precancerous lesions
8. Congenital expression of mdr-1 gene in tissues of carcinoma and its relation with patho-morphology and prognosis
9. Molecular biology of Barrett's esophagus and esophageal cancer: Role of p53
10. p53 anti-cancer gene and digestive system neoplasms
11. Study on the genetic susceptibility of HLA-DQB1 alleles in esophageal cancer of Hubei Chinese Hans
12. Study on genetic polymorphisms of DCC gene VNTR in esophageal cancer
13. WAF1 gene expression with P53 mutation in esophageal carcinoma
14. Relationship between HPV-E6 P53 protein and esophageal squamous cell carcinoma
15. Fas/FasL expression of esophageal squamous cell carcinoma, dysplasia tissues and normal mucosa
16. Association of CD15 antigen expression with cathepsin D in esophageal carcinoma tissues
17. Alterations of tumor suppressor gene system p53-Rb and human esophageal carcinogenesis
18. p53 polymorphism in human papillomavirus-associated esophageal cancer
19. Genetic alterations involving exon 3 of the β-catenin gene do not play a role in adenocarcinomas of the esophagus
20. Primary undifferentiated small cell carcinoma of the esophagus
21. α-difluoromethylornithine inhibits N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in zinc-deficient rats: Effects on esophageal cell proliferation and apoptosis
22. Expression of Bax, a pro-apoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma
23. Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach
24. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma
25. Src activation in malignant and premalignant epithelia of Barrett's esophagus
26. Esophageal carcinosarcoma: A genetic analysis
27. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus
28. LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus
29. Retinoblastoma-protein (pRb) expression and prognosis in squamous-cell carcinomas of the esophagus
30. Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract
31. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers
32. No evidence of mutation in the human PTC gene, responsible for nevoid basal cell carcinoma syndrome, in human primary squamous cell carcinomas of the esophagus and lung
33. Decreased Egr-1 expression in human mouse and rat mammary cells and tissues correlates with tumor formation
34. Hypoxia-associated induction of early growth response-1 gene expression
35. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia
36. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1
37. Regulation of human prohormone convertase 2 promoter activity by the transcription factor EGR-1
38. The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells
39. The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1, and WT1 via non-canonical binding sites
40. Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1
41. Insulin - Induced early growth response gene (Egr-1) mediates a short term repression of rat malic enzyme gene transcription
42. P53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts P53-dependent apoptosis
43. In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an SP1 / Egr-1 binding site and a novel site termed the PyG box
44. Mitogenic Up-regulation of the PRL-1 Protein-tyrosine Phosphatase Gene by Egr-1
45. Activation of luteinizing hormone β gene by gonadotropin-releasing hormone requires the synergy of early growth response-1 and steroidogenic factor-1
46. Sp1 and Egr-1 have opposing effects on the regulation of the rat pgp2/ mdr1b gene
47. The transcription factor Egr-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-β1, fibronectin and plasminogen activator inhibitor-1
48. Inhibition of cell growth by transforming growth factor β1 is associated with p53-independent induction of p21 in gastric carcinoma cells
49. Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2
50. Early growth response-1-dependent Apoptosis is mediated by p53
51. Ionizing radiation-inducible apoptosis in the absence of P53 linked to transcription factor Egr-1
52. Transforming growth factor-α enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter